Literature DB >> 18635581

ADAM10 is essential for proteolytic activation of Notch during thymocyte development.

Lei Tian1, Xiaohui Wu, Congwu Chi, Min Han, Tian Xu, Yuan Zhuang.   

Abstract

Notch signaling pathway has been shown to play essential roles in T lymphocyte development. Activation of Notch requires a sequential proteolytic cleavage, which converts Notch from the full-length membrane-bound form to a transcriptionally active intracellular fragment. Studies in Drosophila showed that Kuzbanian (Kuz) is responsible for the enzymatic cleavage of extracellular S2 site upon Notch binding to its ligand Delta. Both a disintegrin and metalloprotease (ADAM) 10 and ADAM17, members of the ADAM family metalloproteases, have been indicated as the mammalian counterpart of Kuz in activating Notch in mammals. Here, we investigated functions of ADAM10 in Notch signaling during thymocyte development. We show that conditional disruption of the Adam10 gene in mouse thymocytes results in a developmental defect similar to the phenotypes previously described for T lineage-specific disruption of Notch1. We further show that the activation of Notch1 and its downstream target genes Deltex-1 and Pre-Ta are impaired in Adam10-deficient thymocytes. Our study demonstrates a T cell intrinsic role for Adam10 in activation of Notch1 during thymocyte development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18635581     DOI: 10.1093/intimm/dxn076

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  44 in total

Review 1.  Metalloproteinases and their natural inhibitors in inflammation and immunity.

Authors:  Rama Khokha; Aditya Murthy; Ashley Weiss
Journal:  Nat Rev Immunol       Date:  2013-09       Impact factor: 53.106

Review 2.  Role of ADAM10 in intestinal crypt homeostasis and tumorigenesis.

Authors:  Peter J Dempsey
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-07-22       Impact factor: 4.739

3.  Tetraspanin15 regulates cellular trafficking and activity of the ectodomain sheddase ADAM10.

Authors:  Johannes Prox; Michael Willenbrock; Silvio Weber; Tobias Lehmann; Dirk Schmidt-Arras; Ralf Schwanbeck; Paul Saftig; Michael Schwake
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

4.  ADAM10 is required for SCF-induced mast cell migration.

Authors:  Travis W Faber; Nicholas A Pullen; Josephine F A Fernando; Elizabeth Motunrayo Kolawole; Jamie J A McLeod; Marcela Taruselli; Kathryn L Williams; Kevin O Rivera; Brian O Barnstein; Daniel H Conrad; John J Ryan
Journal:  Cell Immunol       Date:  2014-05-21       Impact factor: 4.868

Review 5.  Notch signaling in hematopoietic cell transplantation and T cell alloimmunity.

Authors:  Christen L Ebens; Ivan Maillard
Journal:  Blood Rev       Date:  2013-08-31       Impact factor: 8.250

6.  ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo.

Authors:  David R Gibb; Mohey El Shikh; Dae-Joong Kang; Warren J Rowe; Rania El Sayed; Joanna Cichy; Hideo Yagita; John G Tew; Peter J Dempsey; Howard C Crawford; Daniel H Conrad
Journal:  J Exp Med       Date:  2010-02-15       Impact factor: 14.307

7.  Deficiency of the metalloproteinase-disintegrin ADAM8 is associated with thymic hyper-cellularity.

Authors:  Klaus Gossens; Silvia Naus; Georg A Holländer; Hermann J Ziltener
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

8.  Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch.

Authors:  Desiree H Floyd; Benjamin Kefas; Oleksandr Seleverstov; Olga Mykhaylyk; Charli Dominguez; Laurey Comeau; Christian Plank; Benjamin Purow
Journal:  Neuro Oncol       Date:  2012-09-07       Impact factor: 12.300

Review 9.  Notch Signaling and Alloreactivity.

Authors:  Vedran Radojcic; Ivan Maillard
Journal:  Transplantation       Date:  2016-12       Impact factor: 4.939

10.  Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling.

Authors:  Esra Cagavi Bozkulak; Gerry Weinmaster
Journal:  Mol Cell Biol       Date:  2009-08-24       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.